Trials / Recruiting
RecruitingNCT06278558
Psychological Factors Influencing Cancer Post-traumatic Growth
Study of the Psychological Factors Influencing Post-traumatic Growth During Oncological Pathway
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 289 (estimated)
- Sponsor
- Centre Hospitalier de Valenciennes · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study focuses on post-traumatic growth (positive changes linked to appreciation of life, personal strengths, social relationships...) in the context of different types of cancer and with a longitudinal approach to the care pathway. The aim of the study is to better understand whether psychological variables (emotional competence, psychological flexibility, psychological distress) and patients' care satisfaction, assessed at the start of the cancer treatment pathway, can influence their post-traumatic growth at the end of the chemotherapy protocol and 6 months later.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Interviews with a psychologist/psychiatrist | All patients with a high score (≥11) on the HADS anxiety and/or depressive symptoms scale and who are not already receiving known psychological treatment or treatment mentioned in the file will be contacted by telephone by the investigator or a qualified person designated by him/her in order to conduct a telephone interview with the patient and refer him/her to a psychologist or psychiatrist if necessary. The number and percentage of consultations with a psychologist or psychiatrist following this telephone interview will be calculated in order to highlight the benefits of such a practice (HADS assessment + telephone interview with +/- referral) for earlier and easier referral. Depending on the number of patients contacted, consideration may be given to testing the effect of this approach on post-traumatic development. |
Timeline
- Start date
- 2023-11-10
- Primary completion
- 2026-11-10
- Completion
- 2027-11-10
- First posted
- 2024-02-26
- Last updated
- 2025-03-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06278558. Inclusion in this directory is not an endorsement.